中国当代儿科杂志2024，Vol.26Issue(2)：107-117,11.DOI:10.7499/j.issn.1008-8830.2309059
美罗培南治疗新生儿脓毒症的临床实践指南(2024年版)
Clinical practice guidelines for meropenem therapy in neonatal sepsis(2024)
摘要
Abstract
Meropenem is one of the most widely used special-grade antimicrobial agents in the treatment of neonatal sepsis.However,its irrational use has led to an increasingly severe problem of bacterial multidrug resistance.The guideline was developed following standardized methods and procedures,and provides 12 recommendations specifically addressing 9 clinical issues.The recommendations cover various aspects of meropenem use in neonates,including timing of administration,recommended dosage,extended infusion,monitoring and assessment,antimicrobial adjustment strategies,treatment duration,and treatment strategies for carbapenem-resistant Enterobacteriaceae infections.The aim of the guideline is to provide evidence-based recommendations and guidance for the rational use of meropenem in neonates with sepsis.[Chinese Journal of Contemporary Pediatrics,2024,26(2):107-117]关键词
美罗培南/脓毒症/指南/新生儿Key words
Meropenem/Sepsis/Clinical practice guideline/Neonate引用本文复制引用
《美罗培南治疗新生儿脓毒症的临床实践指南》制订组,北京大学第三医院,《中国当代儿科杂志》编辑部,童笑梅,周文浩,杨克虎..美罗培南治疗新生儿脓毒症的临床实践指南(2024年版)[J].中国当代儿科杂志,2024,26(2):107-117,11.基金项目
国家重点研发计划(2021YFC2700700) （2021YFC2700700）
国家自然科学基金项目(72304008). （72304008）
